Roch Houot
- Oncology top 0.5%
- CAR-T cell therapy research 80
- Cancer Immunotherapy and Biomarkers 24
- Immunology top 1%
- Immune Cell Function and Interaction 28
- Immunotherapy and Immune Responses 19
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 87
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 40
- Hematology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 20
-
- CNS Lymphoma Diagnosis and Treatment 12
- Co-authors
- Aurélien MarabelleRonald LevyHolbrook E. KohrtLambros TselikasThierry de BaèreGuillaume MansonAsh A. AlizadehJune H. Myklebust
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Roch Houot
169 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 2.7k
- Immunology 1.9k
- Pathology and Forensic Medicine 1.5k
- Genetics 631
- Hematology 250
Countries citing papers authored by Roch Houot
This map shows the geographic impact of Roch Houot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roch Houot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roch Houot more than expected).
Fields of papers citing papers by Roch Houot
This network shows the impact of papers produced by Roch Houot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roch Houot. The network helps show where Roch Houot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roch Houot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 13 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 20 | |
| 13 | 2021 | 13 | |
| 14 | 2020 | 45 | |
| 15 | 2019 | 42 | |
| 16 | 2018 | 17 | |
| 17 | 2016 | 123 | |
| 18 | 2013 | 79 | |
| 19 | 2012 | 19 | |
| 20 | 2006 | 96 |
About Roch Houot
Roch Houot is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Microbiology, having authored 181 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (87 papers), CAR-T cell therapy research (80 papers), Chronic Lymphocytic Leukemia Research (40 papers), Immune Cell Function and Interaction (28 papers), Cancer Immunotherapy and Biomarkers (24 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Immunotherapy and Immune Responses (19 papers) and CNS Lymphoma Diagnosis and Treatment (12 papers). The work is most often cited by research in Oncology (2.7k citations), Immunology (1.9k citations), Pathology and Forensic Medicine (1.5k citations), Genetics (631 citations) and Hematology (250 citations). Roch Houot has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Aurélien Marabelle, Ronald Levy, Holbrook E. Kohrt, Lambros Tselikas, Thierry de Baère, Guillaume Manson, Ash A. Alizadeh, June H. Myklebust, Jean Lemoine and Franck Morschhauser. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.